PTCT compared with PLMR: revenue, margins and what each company keeps, and the suppliers and customers both name

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

PLMRPalomar Holdings, Inc.

Mkt capRevenueRevenue

Compare

PTCTPTC Therapeutics, Inc.

PLMRPalomar Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

Q1 FY26±9.4%▲+14.27%×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

PLMR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±7.6%▲+8.07%×1.07

Q2 FY26±8.3%▼−1.55%×0.19

= impliedPTCT realized, solidPLMR realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

Q1 FY26±8.4%▲+2.55%×0.30

Feb 12 '26±7.1%▼−3.52%×0.49

PTCTPTC Therapeutics, Inc.

65.49▼−0.27%· post 65.50

Mkt cap$5.5BRevenue$361MQ2 FY26Revenue$1.7BFY25

PLMRPalomar Holdings, Inc.

156.23▲+0.36%· post 156.23

ClosedNov 6 '26

Mkt cap$4.1BRevenue$381MQ3 FY26Revenue$876MFY25

Compare

ClosedNov 6 '26

PTCTPTC Therapeutics, Inc.

PLMRPalomar Holdings, Inc.

65.49▼−0.27%post 65.50

Price

156.23▲+0.36%post 156.23

$5.5B

Mkt cap

$4.1B

Q2 FY26$361M

Revenue

$381MQ3 FY26

FY25$1.7B

Revenue

$876MFY25

PTCT65.49▼−0.27%vsPLMR156.23▲+0.36%ClosedNov 6 '26